Back
BlackRock Vs. Neurogene Industry Stock Comparison
Sell
47
BLK
BlackRock
Last Price:
$1,040.12
Seasonality Move:
3.72%
Sell
12
NGNE
Neurogene
Last Price:
$22.57
Seasonality Move:
18.83%
Sell
47
BlackRock (BLK)
is a Sell
Is BlackRock a Buy, Sell or Hold?
-
BLK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NGNE Stock Price Chart
BLK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.59 | Buy |
Relative Strength Index (14 RSI): | 47.92 | Sell |
Chaikin Money Flow: | 1069035 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1023.67 - 1053.11) | Sell |
Bollinger Bands (100): | (888.06 - 1030) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.64 | Sell |
Relative Strength Index (14 RSI): | 40.23 | Sell |
Chaikin Money Flow: | -23511 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.09 - 26.45) | Sell |
Bollinger Bands (100): | (26.19 - 50.01) | Sell |
BLK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1044.98 | Sell |
20-day SMA: | 1039.09 | Sell |
50-day SMA: | 1022.33 | Buy |
200-day SMA: | 877.86 | Buy |
8-day EMA: | 1036.95 | Sell |
20-day EMA: | 1037.46 | Sell |
50-day EMA: | 1013.99 | Buy |
200-day EMA: | 903.67 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.05 | Sell |
20-day SMA: | 23.34 | Sell |
50-day SMA: | 37.38 | Sell |
200-day SMA: | 37.89 | Sell |
8-day EMA: | 22.93 | Sell |
20-day EMA: | 25.32 | Sell |
50-day EMA: | 32.11 | Sell |
200-day EMA: | 35.01 | Sell |
BlackRock Earnings Growth & BLK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and an increase next year of $5.27 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
BlackRock Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |